all report title image
  • Published On : Feb 2022
  • Code : CMI4903
  • Industry : Medical Devices
  • Pages : 196
  • Formats :

Single-use products are products such as bioreactors bags that are used once and then discarded in the biopharmaceutical manufacturing process. These single-use products cannot be reused for processing purposes. Plastic, polyethylene, and paper for the filtration unit are the materials used to manufacture these single-use goods. By employing single-use goods, it can save money on high-cost equipment, lower the danger of contamination in cell culture, and cut down on set-up, testing, validation, and documentation time. Moreover, as the global biopharmaceutical market is flourishing for drug development, vaccine production, and other medicinal breakthroughs, thus the market for single-use products used in biopharmaceutical processing is expected to witness growth. For instance, according to India Brand Equity Foundation (IBEF), Indian drugs and pharmaceuticals export has reached US$ 5.78 billion from April 2021 to June 2021.

Global Single Use Products in Biopharmaceuticals Market - Impact of the Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 11, 2021, Single Use Support, a provider and manufacturer of storing, freezing, filing, thawing, and shipping solutions for drug substances, published an article described the shortage on single use assemblies in pharmaceutical market as the research and developments activities increase for vaccine production for COVID 19, where early stage clinical products rely on small volume production for trials and bulk drug requirement can be scaled up to correct volume.

The increasing inorganic activities such as agreements, expansion, and partnerships in different regions by market players for manufacturing single use products in biopharmaceutical is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on November 6, 2020, Cytiva, a technological products and services in field of bioprocessing, manufacturing, research and developments, and provider of therapeutics signed agreements with Wego, Clover is cloud-based Android point of sale platform, Jinbo, and Zhifei a company of high-tech biological enterprise integrating the R&D, production, marketing for investments in the production of therapeutics and to scale up the protein based COVID-19 S-Trimmer subunit vaccine in China.

The global single use products in biopharmaceuticals market is estimated to be valued at US$ 1,821.2 Mn in 2021 and is expected to exhibit a CAGR of 16.7% over the forecast period (2021-2028).  

Figure 1: Global Single Use Products in Biopharmaceuticals Market Share, (%), Analysis, By Product Type, 2021

Single Use Products In Biopharmaceuticals  | Coherent Market Insights

Increasing investment in single use products by the market players used for biopharmaceutical industry is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period.

The increasing investments in single use products for pharmaceutical processing is expected to fuel growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, In December 2019, Lonza, a global partner of biotech, pharmaceutical markets has announced investment of US$ 92 million for building new large scale facility with 20,000L bioreactors to fulfill the market demand of biologics, where single use technology facility will support the clinical manufacturing processes.

Market players are engaged in launching products and applying for approval from regulatory authorities indicated for use in biopharmaceutical processing. This is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period.

Increasing approvals from the regulatory authorities and launches of products are expected to drive growth of the market over the forecast period. For instance, on February 9, 2021, 3M health care, a drug development company’ designed single use AEX solution for biologic drug manufacturing. This manufacturing workflow will help in reducing the number of processing steps of manufacturing product for improving processing.

CMI table icon

Single Use Products in Biopharmaceuticals Market Report Coverage

Report Coverage Details
Base Year: 20120 Market Size in 2021:

US$ 1,821.2 Mn

Historical Data for: 2018 to 2020 Forecast Period: 2021 to 2028
Forecast Period 2021 to 2028 CAGR: 16.7% 2028 Value Projection:

US$ 5,360.5 Mn

Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Product Type: Work Equipment (Flask, Containers, Syringes, Pipettes tips, Centrifuge tubes, Hand Gloves, Face Mask, Filters, Tubes, Others)
  • By Apparatus: Single Use Bioreactor (Isolators, Membrane Valves, Canister, Chromatography Systems, Filtration Systems, Mixing Systems, Others)
  • By End User: Pharmaceutical Companies, Biotechnology Companies, Research Institutes
Companies covered:

Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck , Avantor, Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex,  and Single Use Support GmbH.

Growth Drivers:
  • Increasing investments by market players
  • Increasing product launches and approvals
Restraints & Challenges:
  • Side effects of plastic material used in single use products

 Global Single Use Products in Biopharmaceuticals Market – Regional Analysis

On the basis of region, global single use products in biopharmaceuticals market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

North America is expected to hold a dominant position during the forecast period, owing to the expansion of production unit by market players. For instance, on September 27, 2021, Sartorius AG, a pharmaceutical and laboratory equipment supplier, announced expansion business operations of bioprocessing unit in North America region. This expand will benefit the region because drug availability will grow as transportation costs decrease.

Furthermore, Europe is also estimated to witness a significant growth in the single use products in biopharmaceuticals market, owing to increasing investments by the market players and research institute. For instance, on March 17, 2021, Merck KGaA, which is a company of  leading science and technology announced the expansion of single use assembly production unit in France to manufacture COVID-19 vaccines and therapies and the company has invested US$ 28 million for development of the unit.

Figure 2: Global Single Use Products in Biopharmaceuticals Market (US$ Mn), by Region, 2021

Single Use Products In Biopharmaceuticals  | Coherent Market Insights

Global Single Use Products in Biopharmaceuticals Market – Competitive Landscape

Major players operating in the global single use products in biopharmaceuticals market include Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor, Meissner, New Horizon Biotech, PBS-Biotech,  Xcellerex,  and Single Use Support GmbH.

Single use products used in biopharmaceutical manufacturing process can refer to a product that is used only once and then discard, these single use products cannot be reused for processing purposes. The materials used for manufacturing these single use products are plastic, polyethylene, paper for filtration unit.  Single use products reduces the expenses of high cost equipment, risk of contamination in cell culture, reducing the time, testing, validation, and documentation of manufacturing product. As biopharmaceutical market is booming globally for drug development, vaccine production, and other medicinal innovations, this is expected to drive the market of single use products required in biopharmaceutical processing.

Market Dynamics

Market players are expanding their single use products in biopharmaceuticals market with collaborations with other companies, which is further expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, on September 9, 2021, Cytiva, a provider of technologies and services used in development and manufacture in therapeutics, decided to expand its manufacturing capacity of single use product in biopharmaceutical in China. In collaboration with Wego Pharmaceutical Co., which is a supplier of healthcare technologies will triple the supply capacity of single use product in Asia Pacific by Cytiva.

The increasing research and development, investment activities in pharmaceutical market increases the requirement of single use products and this is expected to drive growth of the global single use products in biopharmaceuticals market over the forecast period. For instance, According to India Brand Equity Foundation (IBEF) data published on December 7, 2021, in which reports that the Indian government has provided policy assistance to the pharmaceutical business, with the Ministry of Finance of India announcing US$ 26,578.3 million in financing for the next five years to increase research and development operations in June 2021.

Key features of the study:

  • This report provides an in-depth analysis of global single use products in biopharmaceutical market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
  • It profiles leading players in the global single use products in biopharmaceutical market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
  • Key companies covered as a part of this study include Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendorf, GE Healthcare, Gemu GmbH, Merck, Avantor , Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex,  and Single Use Support GmbH.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
  • The global single use products in biopharmaceutical market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global single use products in biopharmaceutical market

Detailed Segmentation:

  • Global Single Use Products in Biopharmaceutical Market, By Product Type:
    • Work Equipment
      • Flask
      • Containers
      • Syringes
      • Pipettes Tips
      • Centrifuge Tubes
      • Hand Gloves
      • Face Mask
      • Filters
      • Tubes
      • Others
    • By Apparatus:
      • Single Use Bioreactor
      • Isolators
      • Membrane Valves
      • Canister
      • Chromatography Systems
      • Filtration Systems
      • Mixing Systems
      • Others
  • Global Single Use Products in Biopharmaceutical Market, By End User:
    • Pharmaceutical Companies
    • Biotechnology Companies
    • Research Institutes
  • Global Single Use Products in Biopharmaceutical Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
  • Company Profiles
    • Aber instruments *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Adolf Kühner AG
    • Thermo Fisher Scientific 
    • Bio-equip
    • Pall corp.
    • C-Cit Sensors AG
    • Corning Life Sciences
    • Eppendorf
    • GE Healthcare
    • Gemu GmbH
    • Merck
    • Avantor
    • Meissner
    • New Horizon Biotech 
    • PBS-Biotech
    • Xcellerex
    • Single Use Support GmbH

 “*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global single use products in biopharmaceuticals market is expected to exhibit a CAGR of 16.7% during the forecast period (2021-2028).
The market is estimated to be valued at US$ 1,821.2 Mn in 2021.
Aber instruments, Adolf Kühner AG, Thermo Fisher Scientific, Bio-equip, Pall corp., C-Cit Sensors AG, Corning Life Sciences, Eppendrof, GE Healthcare, Gemu GmbH, Merck, Avantor, Meissner, New Horizon Biotech, PBS-Biotech, Xcellerex, and Single Use Support GmbH are some of the prominent players operating in the market over the forecast period.
The market is expected to be valued at US$ 5,360.5 Mn in 2021.
North America is the prominent region in the market.
Single use bioreactor, which belongs to the apparatus segment, is the prominent segment in the market.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo